Summary Rabbits treated with an immunosuppressive dose of cyclosporine for a prolonged period of time developed a clinically distinct toxic syndrome characterized by wasting, loss of weight, reduced food and water consumption and reduced movement. Ultimately 74 of 153 animals died within 60 days of treatment with a distended stomach and intestines full of dry undigested food. The syndrome was dose dependent but seemed unrelated to the route of administration. It occurred in two strains and two different colonies. No infectious agent was implicated. Histological examination and a variety of laboratory tests did not elucidate the syndrome. It could not be prevented by drugs that increased bowel movement or gastric emptying and was more pronounced in animals given additional indomethacin. Reduction of cyclosporine dose reduced toxicity but at the expense of reduced immunosuppression. We were unable to define a therapeutic non-toxic range by serial determination of cyclosporine blood concentrations. This highlights the difficulty in obtaining a therapeutic dosage level in rabbits on long-term cyclosporine immunosuppression.
Summary
Rabbits treated with an immunosuppressive dose of cyclosporine for a prolonged period of time developed a clinically distinct toxic syndrome characterized by wasting, loss of weight, reduced food and water consumption and reduced movement. Ultimately 74 of 153 animals died within 60 days of treatment with a distended stomach and intestines full of dry undigested food. The syndrome was dose dependent but seemed unrelated to the route of administration. It occurred in two strains and two different colonies. No infectious agent was implicated. Histological examination and a variety of laboratory tests did not elucidate the syndrome. It could not be prevented by drugs that increased bowel movement or gastric emptying and was more pronounced in animals given additional indomethacin. Reduction of cyclosporine dose reduced toxicity but at the expense of reduced immunosuppression. We were unable to define a therapeutic non-toxic range by serial determination of cyclosporine blood concentrations. This highlights the difficulty in obtaining a therapeutic dosage level in rabbits on long-term cyclosporine immunosuppression. Keywords: Rabbits; Cyclosporines; Toxicology Cyclosporine, a novel type of immunosuppressive agent (Borel et al., 1976) , is the therapy of choice following organ transplantation at many centres worldwide (Cohen et al., 1984) . It specifically inhibits the proliferation of T cells and, in contrast with classical immunosuppressive drugs, is devoid of haematological toxicity. However, it is not free of side effects and nephrotoxicity is the most frequent dose-limiting side effect in man. Other side effects, mainly neurotoxicity, hepatotoxicity and vascular toxicity, have been well described (Borel, 1985) . Unlike the extensive studies in man, few toxicity data are available from animals. In one recent study, conducted in several species, cyclosporine was reported to be relatively non-toxic and essentially free of side effects at 'normal dose' in rabbits (Ryffel et 01., 1983) . In contrast with this study we have observed severe toxicity in our rabbits, even in our initial experiments (Gratwohl, Forster & Speck, Materials and methods All experiments described were part of our studies to understand effector cell mechanisms in skin and bone marrow allografts and to prevent rejection or graft-versus-host disease (Gratwohl, Forster & Speck, 1981 , 1982 Gratwohl et 01., 1984) . They were not intended as toxicological studies. Cyclosporine toxicity was an added complication and changes in the schedules of cyclosporine were sought arbitrarily to avoid this toxicity. Owing to the additional complications and problems of total body irradiation and graft-versus-host disease in bonemarrow-transplanted animals, we restricted the analysis to animals given cyclosporine alone or with a skin graft, even though the toxicity in bonemarrow-grafted animals was identical or even more accentuated (Gratwohl, Forster & Speck, 1982; Gratwohl et 01., 1984) .
Animals
Outbred New Zealand White (NZW) and Red Burgundy (RB) adult rabbits were used in all experiments. They were all less than 1 year old but with a minimal weight of 2·5 kg (NZW) or 3 kg (RB). An equal number of male and female rabbits was normally used in all groups. Animals were housed in single cages 33 cm high, 45 cm wide and 54 em in depth. The animal care facility is air conditioned with a constant temperature of 20°C and 68-70% relative humidity and there is artificial light for 10 h daily. Animals received pellet cereal-based diet (Nafar 814: Nafar Ltd, Gossau, Switzerland) and water ad libillllll. They were given a daily clinical examination and urine, faeces and bodyweight were recorded.
Study groups
A total of 153 rabbits are described in this report. The individual groups and their therapy arc shown in Table 1 . Most animals were treated with 15 mglkg of cyclosporine given subcutaneously once daily for 60 days. This schedule leads to sustained engraftment of transplanted skins (Gratwohl, Forster & Speck, 1981 . 1982 . Groups 1-10 included animals treated with increasing doses of cyclosporine for 60 days by different routes of administration following an allogeneic skin graft. Groups 11-15 included animals treated with cyclosporine for 60 days and examined on days 10, 20 and 30 for determination of cerebrospinal fluid levels of cyclosporine. Groups 16-21 summarize the experiments of an 'intervention' group where we tried to prevent or to treat gastrointestinal toxicity. Prostigmine was given to promote gastrointestinal motility, paraffin oil to ease bowel emptying, paspertine and prednisolone to relax the pyloric sphincter and indomethacin to block prostaglandin synthesis. In groups 22-27 the dose of cyclosporine was reduced after the initial loading, either arbitrarily or depending on serum creatinine level and cyclosporine blood concentration.
Skin graft
Full thickness 1 Col x 1 Col skin grafts were performed to monitor the immunosuppressive activity of cyclosporine (Gratwohl, Forster & Speck, 1981) . RB rabbits normally served as donors for NZW recipients except for groups 5, 17 and 18 where NZW rabbits were used as donors for RB recipients.
These two strains are strongly histoincompatible (Cornu et al., 1979) . Skin grafts were given to all animals except those in groups 11-15, 20 and 21. Cyclosporine was always started 1 day before the skin graft (day -1).
Cyclosporine
Cyclosporine was kindly provided by Sandoz Ltd, Basel. The same preparations were used as in clinical practice. Solvents for cyclosporine are olive oil for the oral formula, miglyol for the subcutaneous formula and cremophor for the intravenous formula.
Subcutaneous cyclosporine was injected daily at different sites, progressing over the back. Intravenous cyclosporine was administered in a solution with normal saline at 1:3 to 1:4 dilution as a slow 2-3 min infusion into an ear vein. The drinking solution was instilled undiluted at the back of the throat with a syringe. Serum, whole blood and cerebrospinal fluid levels of cyclosporine were determined in selected groups using a standard Sandoz RIA kit as described previously (Donatsch et al., 1981) . Cerebrospinal fluid was obtained by puncture of the cysterna cere bello medullaris under general anaesthesia.
Laboratory tests
In group 1, complete blood counts including haemoglobin, differential white blood smear and platelet counts were performed in all animals twice a week, as well as liver function tests (SGOT, SGPT, bilirubin, alkaline phosphatase).
In the other groups these determinations were performed randomly in selected animals. Cyclosporine blood concentrations were monitored throughout the whole study period. In all animals of group 1 serum and heparinized whole blood cyclosporine concentrations were determined 2, 4, 6 and 24 h after one injection to determine the pharmacokinetics of cyclosporine. In groups 11-15 cyclosporine baseline serum concentrations before the subsequent injection and cyclosporine cerebrospinal fluid levels were determined 215 in all animals on days 10, 20 and 30. In groups 24, 25, 26 and 27 heparinized whole blood cyclosporine baseline levels were determined twice weekly throughout the whole treatment period. Measurements were made in all animals in the abovementioned groups. In the other groups determinations of cyclosporine blood concentrations were made randomly in selected animals at various times.
Post-mortem examination
All animals that died had a post-mortem examination with gross examination of lungs, heart, stomach, intestines, kidneys, bladder and urogenital system. In group 1 all animals had a complete histological examination.
In all other groups histological examination was performed randomly in selected animals. In group 11 two animals had an electromyographic examination when they showed signs of paresis. Under anaesthesia with Ketalar®, potentials of the tibialis anterior and gastrocnemius muscles were determined using a standard electromyogram. These two animals were electively killed when they were ill. In situ preparations of their vagus, saphenous and peroneus nerves and of their spinal cord were made for specific neurohistological examination. The brain was examined histologically for five animals.
Results

Clinical signs and symptoms
No acute toxicity was seen over the first few days in animals given cyclosporine subcutaneously or orally. After intravenous injection, however, three animals in the first group of animals had generalized seizures and died. In subsequent studies where cydosporine was given intravenously (25 mglkg once or twice weekly; groups 23 and 24), administration of cyclosporine was prolonged over a period of 3-5 min.
Using this slow infusion no fits or other signs of acute toxicity were observed. All animals in all groups given enough cyclosporine to prevent rejection showed signs of severe chronic toxicity and 74 of 153 animals ultimately died as a consequence of this toxicity. The clinical syndrome was uniform. After only 5 days of therapy, animals started losing weight; they gradually stopped eating and drinking and their faeces became small and sparse. After 3-5 weeks, the animals became apathetic and stopped moving in their cages. Some animals-clearly showed signs of paresis of their hind limbs. In the final stages, animals became extremely wasted with a complete lack of subcutaneous fat. Animals surviving the 60 day treatment period normally recovered, although a few animals died after cyclosporine was stopped. The exact percentage cannot be given. After the initial experience animals were often electively killed when they were severely ill or at day 60 or, after cyclosporine was stopped, at the day of skin rejection in those animals rejecting. Weight loss per se did not cause death and varied widely between the different groups (Table 2 ). It was low in the intravenous group 10 although toxicity in this group was high, leading to death of all animals within 21 days compared with the mean day of death at day 45. The variation and the poor correlation between weight loss and lethal outcome might be due to the fact that, at least in some animals, the stomach was grossly enlarged. The weight of the stomach, as much as 900 g, greatly Gratwohl, Riederer, Graf & Speck contributed to the weight of the animal. Indeed, spontaneous rupture of the stomach directly caused the death of some animals. About a third of the animals had diarrhoea in the form of loose stools and soiled perineum despite the reduction in faeces and a clinically palpable enlarged stomach.
A second clinical observation in about 20% of the initially treated animals was an infection below the chin with loss of hair and severe skin irritation. Histological examination did not reveal any specific abnormalities other than the inflammatory changes. On two occasions Pseudomonas aeruginosa could be cultivated and in later experiments these skin lesions Total number of deaths 48%. "nitial weight 100%; weight loss until day of death or day 60. tIn animals rejecting skin grafts, eyclosporine was stopped at the time of rejection. could be partially treated and prevented with local disinfectants such as Betadine® or Merfen® in 80% alcohol. A few male rabbits developed a painful swelling of the testicles.
Post-mortem examination
The most obvious and also most constant finding was a grossly enlarged stomach containing dried undigested food and faeces. The large intestine also was frequently found to be full with very hard faeces. The second constant finding was an almost complete atrophy of adipose tissue. All other organs appeared normal upon macroscopic examination. Histological examination showed no consistent abnormalities of the gastric mucosa, the pylorus and the intestines, kidneys, liver and lungs. Two clinically ill animals with signs of paresis showed abnormal potentials on electromyography compatible with a peripheral neuropathy. The specific neurohistological examination performed in these animals, however, did not show any specific lesions in peripheral sensory or motor nerves except for non-specific mild atrophy. Their nervus vagus and spinal cord were normal. Brains appeared normal apart from one brain where possible Encephalitozoon cuniculi could be demonstrated but any influence of this parasite on the syndrome was excluded.
Screening of our colony for antibodies to E. cuniculi as a marker for carrier animals showed that about half of our animals are carriers. There was no difference in survival and toxicity between carriers and those animals free of E. cuniculi, however, and survival was identical in the animals of a parasitefree colony at another institution treated for 60 days with cyclosporine (group 21). 27). In group 25 dose reduction was attempted depending on creatinine or cyclosporine concentrations. The final evaluation was disappointing (Fig. 1,  Table 2 ). Of the 25 animals, seven died and eight rejected their skin grafts; only 10 animals survived the 60 days of treatment with sustained skin grafts. The results of cyclosporine concentrations and serum creatinine levels, however, did not differ between those animals surviving, those dying and those rejecting. This reflects the absence of a therapeutic window. No correlation could be found between cyclosporine concentration, serum creatinine and weight loss.
Cyclosporine crosses the blood-brain barrier to a limited extent and could be detected in low concentrations in most animals tested. Cyclosporine cerebrospinal fluid levels stayed constant throughout the whole 30 day period and were not correlated with baseline blood cyclosporine concentrations. There was no correlation between cyclosporine cerebrospinal fluid levels (Table 3) ' and toxicity. 
Laboratory tests
Haematological parameters such as haemoglobin, white blood cell count and white blood cell differential remained relatively unchanged throughout the observation period in those animals tested. Liver function tests were also normal for the whole period. Serum creatinine slightly increased but then remained constant despite further clinical deterioration of the animals. Renal insufficiency did not contribute to the lethal outcome. Very high creatinine values of more than 500 J,lmoUIcould be found in a few animals tested immediately before death when they were moribund. In groups 24, 25, 26 and 27 we tried to prevent toxicity by adapting the scheduled dose of cyclosporine. After an initial constant dose of 15 mg/kg per day subcutaneously, the daily doses were reduced to twice weekly injections at constant dose (group 24) or further reduced dose (groups 26 and Discussion We describe in this report a syndrome unique to the rabbit, occurring in all animals treated for a prolonged period of time with cyclosporine at an immunosuppressive dose. This syndrome is clearly caused by cyclosporine.
It has never been seen in any rabbit in our colony not treated with cyclosporine. It is clearly dose related, occurring less frequently and with lower mortality in animals given a non-immunosuppressive dose, as reported earlier (Gratwohl, Forster & Speck, 1981) . This excludes the possibility that the syndrome was induced by stress, since the handling of the animals was exactly the same except for the low dose of cyclosporine. Attempts to overcome the toxicity by reducing the dose or increasing the interval between the doses resulted in a lower mortality rate but at the expense of skin graft rejection.
This toxicity is not strain specific. It occurs in NZW rabbits as well as in RB rabbits and it is not specific to our colony. Rabbits treated at another institution (group 21) by an independent observer and given the same dose of cyclosporine showed exactly the same clinical syndrome. In addition, the description of the animals treated by Ryffel et al. (1983) with 150 and 300 mg orally fits in well with our syndrome.
Similarly the severe toxicity described by others (Bell, Gasty & McCullagh, 1982; Smith, 1982; Kemp et al., 1985) is probably due to the same syndrome.
The paucity of reports of toxicity so far can easily be explained. Animals were either treated for; short periods (Green & Allison, 1978; Green et al., 1982; Neild, Ivory & Williams, 1983 Neild et al., 1983a; Diperink & Starklint, 1984; King, Clunie & Dumble, 1984) or the 'normal' dose was thought to be 30 mg/kg orally daily (Ryffel et al., 1983) . As we know today, this dose is well below the therapeutic range. Cyclosporine is poorly absorbed from the gastrointestinal tract in the rabbit (Gratwohl et al., 1983; Maurer, 1983) .
The mechanisms leading to death remain unclear. Initially we observed severe skin infections and we suspected an infectious origin. The local infection, however, could be treated without affecting the general outcome.
Bacterial and histological examinations of the gastrointestinal tract and of other organs did not reveal a specific infectious agent or show inflammatory reactions. E. cuniculi, a parasite common in free and laboratory rabbits, can lead to a wasting syndrome, kidney failure and neurological symptoms similar to the syndrome we observed (Koller, 1969; Wilson, 1979) . Antibody screening (Waller, 1977) did indeed reveal that about 50% of our rabbits are infected and are carriers of E. cuniculi (T. Waller, unpublished death, but in a group of 10 animals in a strictly parasite-free colony the same syndrome was observed at the same rate and intensity. This makes it unlikely that an infection aggravated by cyclosporine causes the toxicity. The same absence of any histological finding in rabbits dying of cyclosporine toxicity has also been observed recently by Kemp et al. (1985) .
Renal failure is the major toxicity in man and the leading cause of death in susceptible rats (Borel, 1986) . Cyclosporine is slightly nephrotoxic in rabbits, but serum creatinine rises only to a mild extent and mainly after weight loss starts to occur. High creatinine levels are only observed in moribund animals when they have stopped eating and drinking. Nephrotoxicity per se is therefore not the cause of this syndrome. This is emphasized by the fact that no abnormal histological findings were found in the kidneys of these animals.
Cyclosporine can be neurotoxic. It is known to cause fits, tremor and an ill-defined central nervous system syndrome in man (Cohen etal., 1984; Borel, 1985) . Cyclosporine induced fits in our rabbits treated intravenously and animals in all groups showed signs of paresis when they were severely ill. Electromyographic examination suggested a peripheral neuropathy.
Specific examination of the nerves, however, could not explain the syndrome. It is unlikely that passage of the lipophilic cyclosporine into the cerebrospinal fluid is the cause. Cyclosporine levels in the cerebrospinal fluid were low, similar in orally, subcutaneously or intravenously treated animals, and did not correlate with serum levels.
We tried to prevent this syndrome by administration of prednisolone, prostigmine, paraffin oil or paspertine, all in an attempt to promote gastrointestinal motility and emptying of stomach and bowel. We were unsuccessful. We also failed with a trial of baby-formula milk and with strictly parenteral nutrition and no food intake. Rabbits ate their faeces and their stomachs filled up despite our attempts to withhold non-absorbable nutrition. Indomethacin given to prevent prostaglandin synthesis aggravated the toxicity. We thought at the time of the experiment that excessive prostaglandin synthesis could be the cause of the syndrome. In a study with rats the injection of prostaglandin E reduced cyclosporine nephrotoxicity (Makowka et al., 1985) . Neild et al. (1983b) showed that cyclosporine blocks prostacycline synthesis by the aortic wall in rabbits and these observations, together with clinical findings of a haemolytic uraemic syndrome in some patients (Leithner et al., 1982) , suggest that cyclosporine toxicity could be mediated by an interference with prostaglandin synthesis.
The question remains of the therapeutic range of cyclosporine in rabbits. So far, toxicity has paralleled the therapeutic dose. As clearly shown in the last groups, the ideal of survival of skin graft and animal could not be reached. So far we lack an explanation for this finding. Analysis of selected blood samples for cyclosporine determination by high pressure liquid chromatography did not show a difference. This excludes the possibility that different rates in the metabolism of cyclosporine could account for the different results in the individual rabbits and suggests a true absence of a therapeutic window in rabbits. These results must be considered in any study using rabbits with a long-term dosing of cyclosporine.
They also warn that toxicological studies depend on the absorption of the drug being tested (Ryffel et al., 1983) . At this moment we lack an explanation for our findings, but elucidation of this cyclosporine-induced syndrome could give us more insight into the mechanism of toxicity and activity of cyclosporine.
